LAWSUITS NEWS & LEGAL INFORMATION
Prozac Linked to Suicide
Documents have been found showing that Eli Lilly and Co. allegedly knew more than 15 years ago, that patients using Prozac had an increased tendency towards commiting suicide. Elevated levels of hostility and suicidal tendencies were much higher in patients taking Prozac than in patients on other antidepressants.
According to the 1988 document, 3.7 percent of patients taking Prozac tried to commit suicide - more than 12 times the rate of patients taking other popular antidepressants.
The document also revealed that 2.3 percent of Prozac users suffered psychotic depression, more than twice the rate of patients on other antidepressants. Prozac users also had elevated incidents of hostility and intentional injury, and experienced other side effects such as nervousness, insomnia, anxiety, panic attacks, aggressiveness and agitation.
According to the 1988 document, 3.7 percent of patients taking Prozac tried to commit suicide - more than 12 times the rate of patients taking other popular antidepressants.
The document also revealed that 2.3 percent of Prozac users suffered psychotic depression, more than twice the rate of patients on other antidepressants. Prozac users also had elevated incidents of hostility and intentional injury, and experienced other side effects such as nervousness, insomnia, anxiety, panic attacks, aggressiveness and agitation.
Register your Prozac Case
If you or a loved one has taken Prozac and has attempted or committed suicide, you may qualify for damages or remedies that might be awarded in a possible Prozac suicide lawsuit. Please click on the link below to submit your story.Last updated on
LEGAL ARTICLES AND INTERVIEWS
Generic Prozac Ruling: "Another Nail in Preemption's Coffin"
April 8, 2010
Is a generic manufacturer of a name-brand drug like Prozac hamstrung by federal rules that govern the labeling of the drug originally approved by the US Food and Drug Administration (FDA)? Or does a generic manufacturer have the right and responsibility to alter the labeling of its generic drug in an effort to warn consumers and the health care community about potential adverse reactions? READ MORE
READ MORE Drugs/Medical Settlements and Legal News
READER COMMENTS
Arizona
on